Published in Gut on April 28, 2008
Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease | NCT01244386
Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin Gastroenterol Hepatol (2009) 2.72
Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn's disease. Clin Gastroenterol Hepatol (2011) 2.40
Risk stratification of emergency department patients with Crohn's disease could reduce computed tomography use by nearly half. Clin Gastroenterol Hepatol (2014) 2.08
Radiation exposure from diagnostic imaging studies among patients with inflammatory bowel disease in a safety-net health-care system. Dig Dis Sci (2013) 1.42
Predictors of Urgent Findings on Abdominopelvic CT in Patients with Crohn's Disease Presenting to the Emergency Department. Dig Dis Sci (2014) 1.40
Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol (2011) 1.20
Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatr Radiol (2012) 1.18
Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review. Eur Radiol (2009) 1.02
Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease. Therap Adv Gastroenterol (2011) 0.99
An assessment of medical students' awareness of radiation exposures associated with diagnostic imaging investigations. Insights Imaging (2010) 0.99
Magnetic resonance enterography in Crohn's disease: Standard and advanced techniques. World J Radiol (2010) 0.96
MRI in patients with inflammatory bowel disease. J Magn Reson Imaging (2011) 0.95
Use of small bowel imaging for the diagnosis and staging of Crohn's disease--a survey of current UK practice. Br J Radiol (2010) 0.93
Radiation associated tumors following therapeutic cranial radiation. Surg Neurol Int (2012) 0.92
Detecting active inflammation and fibrosis in pediatric Crohn's disease: prospective evaluation of MR-E and CT-E. Abdom Imaging (2013) 0.90
A prospective feasibility study of sub-millisievert abdominopelvic CT using iterative reconstruction in Crohn's disease. Eur Radiol (2013) 0.88
Limitations in assessment of mucosal healing in inflammatory bowel disease. World J Gastroenterol (2010) 0.88
Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease. Dig Dis Sci (2011) 0.87
Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases. Am J Gastroenterol (2009) 0.86
Computed tomography enterography for evaluation of inflammatory bowel disease. Clin Endosc (2013) 0.86
Should computed tomography be the modality of choice for imaging Crohn's disease in children? The radiation risk perspective. Gut (2008) 0.85
Clinical predictors of urgent findings on abdominopelvic CT in emergency department patients with Crohn's disease. Inflamm Bowel Dis (2013) 0.85
The first joint ESGAR/ ESPR consensus statement on the technical performance of cross-sectional small bowel and colonic imaging. Eur Radiol (2016) 0.84
Radiation exposure from abdominal imaging studies in patients with intestinal Behçet disease. Gut Liver (2013) 0.83
Outcomes of computed tomography and magnetic resonance enterography in clinical practice of inflammatory bowel disease. Dig Dis Sci (2013) 0.83
Differential diagnosis between Crohn's disease and intestinal tuberculosis using integrated parameters including clinical manifestations, T-SPOT, endoscopy and CT enterography. Int J Clin Exp Med (2015) 0.83
Radiation exposure from diagnostic imaging in young patients with testicular cancer. Eur Radiol (2014) 0.80
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. World J Gastroenterol (2012) 0.80
Inflammatory bowel disease imaging: Current practice and future directions. World J Gastroenterol (2016) 0.78
Small bowel imaging in managing Crohn's disease patients. Gastroenterol Res Pract (2012) 0.78
Minimization of Radiation Exposure due to Computed Tomography in Inflammatory Bowel Disease. ISRN Gastroenterol (2012) 0.77
Role of wireless capsule endoscopy in inflammatory bowel disease. World J Gastrointest Endosc (2010) 0.76
Pediatric Magnetic Resonance Enterography: Focused on Crohn's Disease. Pediatr Gastroenterol Hepatol Nutr (2015) 0.76
Magnetic resonance enterography for the evaluation of the deep small intestine in Crohn's disease. Intest Res (2016) 0.76
Small bowel imaging of inflammatory bowel disease. World J Radiol (2015) 0.75
Cumulative radiation exposure from diagnostic imaging in intensive care unit patients. World J Radiol (2016) 0.75
Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound. World J Gastroenterol (2017) 0.75
The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response. Gastroenterol Res Pract (2015) 0.75
Levels of Faecal Calprotectin and Magnetic Resonance Enterocolonography Correlate with Severity of Small Bowel Crohn's Disease: A Retrospective Cohort Study. Sci Rep (2017) 0.75
Computed tomography and patient risk: Facts, perceptions and uncertainties. World J Radiol (2016) 0.75
Surgery and diagnostic imaging in abdominal Crohn's disease. J Ultrasound (2013) 0.75
Diagnostic imaging and radiation exposure in inflammatory bowel disease. World J Gastroenterol (2016) 0.75
SICUS and CEUS imaging in Crohn's disease: an update. J Ultrasound (2017) 0.75
Radiation dose from medical imaging: a primer for emergency physicians. West J Emerg Med (2012) 0.75
The Diagnostic Role of Magnetic Resonance Enterography as a Complementary Test to Colonoscopy in Active Crohn's Disease. Middle East J Dig Dis (2016) 0.75
Magnetic resonance enterography: A stepwise interpretation approach and role of imaging in management of adult Crohn's disease. Indian J Radiol Imaging (2016) 0.75
Does radiation exposure from abdominal computed tomography increase cancer risk in patients with inflammatory bowel disease and Behçet disease? Gut Liver (2014) 0.75
Imaging of the small bowel: Crohn's disease in paediatric patients. World J Radiol (2014) 0.75
Transitioning patients with inflammatory bowel disease (IBD) from adolescent to adult services: a systematic review. Frontline Gastroenterol (2015) 0.75
An overview of magnetic resonance enterography for Crohn's disease. Dig Dis Sci (2014) 0.75
A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg (1995) 4.24
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut (2010) 3.67
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med (1996) 3.56
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet (1994) 3.22
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res (2000) 3.01
A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol (1990) 2.98
Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology (1991) 2.93
In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr (2001) 2.73
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol (1995) 2.73
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol (1991) 2.58
Perceived information needs and communication difficulties of inpatient physicians and nurses. Proc AMIA Symp (2001) 2.43
Pathways of activation of the Epstein-Barr virus productive cycle. J Virol (1991) 2.42
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut (2003) 2.37
Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut (1993) 2.35
Bacterial endotoxin is an active component of cigarette smoke. Chest (1999) 2.35
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry (2012) 2.16
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek (1999) 2.14
Insulin-dependent diabetes mellitus and coeliac disease. Lancet (1997) 2.14
Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology (1993) 2.10
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. Ann Intern Med (1991) 2.03
Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther (2001) 1.97
p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J (1991) 1.91
Quantification of the placebo response in ulcerative colitis. Gastroenterology (1997) 1.86
Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol (1985) 1.85
Rotavirus serotypes 6 and 10 predominate in cattle. J Clin Microbiol (1990) 1.81
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Haemorrhagic colitis in child after visit to farm visitor centre. Lancet (1995) 1.79
The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol (1998) 1.78
Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci U S A (1989) 1.77
Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut (1999) 1.75
Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy (2010) 1.73
Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol (2002) 1.68
Impact of early intervention on outcome following mild head injury in adults. J Neurol Neurosurg Psychiatry (2002) 1.67
Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure? Hum Pathol (1998) 1.65
The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival. Am J Gastroenterol (2000) 1.65
Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM (1997) 1.63
Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil (2008) 1.62
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry (2004) 1.60
Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene (1996) 1.58
Factors influencing outcome following mild traumatic brain injury in adults. J Int Neuropsychol Soc (2000) 1.56
Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol (1991) 1.55
Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat (2010) 1.54
A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol (1995) 1.53
Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol (1998) 1.52
Haemophilus influenza type b resistant to both chloramphenicol and ampicillin in Britain. Br Med J (Clin Res Ed) (1982) 1.46
Increased soluble interleukin 2 receptor levels in schizophrenia. Schizophr Res (1998) 1.45
Immune privilege or inflammation? Insights into the Fas ligand enigma. Nat Med (2001) 1.45
Risk factors and early detection of lung cancer in a cohort of Chinese tin miners. Ann Epidemiol (1997) 1.42
Lack of an association between polymorphisms of the T-cell receptor alpha-chain and ulcerative colitis. Gastroenterology (1989) 1.42
Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc (1995) 1.41
Case of the month: congenital unilateral proptosis. Br J Radiol (2002) 1.41
Braving the elementals in Crohn's disease. Gastroenterology (1992) 1.41
The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM (2000) 1.41
Critical appraisal of enteral nutrition as primary therapy in adults with Crohn's disease. Am J Gastroenterol (1996) 1.39
Factor XIII: is it a factor in Crohn's disease? Gastroenterology (1993) 1.39
Cognitive and behavioral outcome following mild traumatic head injury in children. J Head Trauma Rehabil (1999) 1.39
Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. Gastroenterology (1999) 1.38
Nurse/physician relationships: getting things rolling. Crit Care Nurse (1992) 1.37
Impact of early intervention on outcome after mild traumatic brain injury in children. Pediatrics (2001) 1.34
PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection. Gut (2002) 1.31
The Fas counterattack: cancer as a site of immune privilege. Immunol Today (1999) 1.28
Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax (2003) 1.28
Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect Immun (2000) 1.23
Immunologic mechanisms in intestinal diseases. Ann Intern Med (1987) 1.23
Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet (1996) 1.23
An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol (1999) 1.23
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents. Oncogene (2001) 1.18
Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. J Pathol (1998) 1.18
Epstein-Barr virus SM protein. Virology (1994) 1.18
Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res (1995) 1.18
Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population. Hepatology (2000) 1.17
Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. Q J Med (1982) 1.17
Informatics competencies for nurses at four levels of practice. J Nurs Educ (2001) 1.17
Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut (2000) 1.15
Dermatomyositis: A study of five cases. Am J Pathol (1940) 1.15
Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum (2002) 1.15
Is nutrition an aetiological factor for inflammatory bowel disease? Eur J Gastroenterol Hepatol (2003) 1.14
Micrometastases: marker of metastatic potential or evidence of residual disease? Gut (1997) 1.14
Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells. Antiviral Res (1998) 1.13
Coeliac disease and epilepsy. QJM (1998) 1.12
High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol (1997) 1.11
Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther (2005) 1.09
Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. Ann N Y Acad Sci (2000) 1.09
Fas counter-attack--the best form of tumor defense? Nat Med (1999) 1.08
Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. J Immunol (1998) 1.08
Nonequilibrium freezing of one-cell mouse embryos. Membrane integrity and developmental potential. Biophys J (1993) 1.08
Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics. Ir J Med Sci (2009) 1.07
Fas ligand upregulation is an early event in colonic carcinogenesis. J Clin Pathol (2001) 1.07
Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology (1999) 1.07
The influence of endorphins on peritoneal and mucosal mast cell secretion. J Allergy Clin Immunol (1984) 1.07
Effects of strength or aerobic training on body composition, resting metabolic rate, and peak oxygen consumption in obese dieting subjects. Am J Clin Nutr (1997) 1.06
State-of-the-art imaging of pancreatic neoplasms. Br J Radiol (2003) 1.05
HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology (2001) 1.05
Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis. J Cell Physiol (2000) 1.04
Intestinal mucosal mast cells: isolation from rat lamina propria and purification using unit gravity velocity sedimentation. Immunology (1985) 1.03
Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort. Breast Cancer Res Treat (2009) 1.03
First isolation of Lyme disease spirochete, Borrelia burgdorferi, from blacklegged tick, Ixodes scapularis, removed from a bird in nova Scotia, Canada. Can Commun Dis Rep (1999) 1.03
Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. Br J Cancer (2003) 1.03